Off Patent
June 2026

Supprelin LA

histrelin acetate

Endo Operations Ltd

Implant (subcutaneous) · NDA 022058

Last listed protection ended
June 16, 2026

The FDA listed 1 patent for Supprelin LA, and this is the day the last one ended. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Ended
    Patent 8,062,652
    Claims a use (U-1197)